KRT9 Antibody (Center K444) Blocking Peptide
€363.00
In stock
SKU
AC-BP7312c
Background:
KRT9 is the type I keratin 9, an intermediate filament chain expressed only in the terminally differentiated epidermis of palms and soles. Mutations in this protein cause epidermolytic palmoplantar keratoderma.
Other Names:
Keratin, type I cytoskeletal 9, Cytokeratin-9, CK-9, Keratin-9, K9, KRT9
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP7312c was selected from the Center region of human KRT9. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: KRT9
Gene ID: 3857
Primary Accession: P35527
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
KRT9 is the type I keratin 9, an intermediate filament chain expressed only in the terminally differentiated epidermis of palms and soles. Mutations in this protein cause epidermolytic palmoplantar keratoderma.
Other Names:
Keratin, type I cytoskeletal 9, Cytokeratin-9, CK-9, Keratin-9, K9, KRT9
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP7312c was selected from the Center region of human KRT9. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: KRT9
Gene ID: 3857
Primary Accession: P35527
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review